Stem Cell Therapy Could Work Against Virus

Researchers are on the forefront of finding treatments.

The coronavirus has killed more than 4,500 people in the United States as of Wednesday morning. The race remains strong to find a vaccine along with other treatments to help save lives of those already infected.

Athesersys, Inc., a Cleveland, Ohio-based biotech company is at the front of that research. They have developed a treatment using stem cell therapy, called MultiStem, for patients with acute respiratory distress syndrome (ARDS), one of the more serious and deadly possible side effects for COVID-19 patients.

“ARDS is the primary cause of death among patients that are infected with COVID-19,” Athersys CEO Gil Van Bokkelen said. “Like other viral pathogens, including SARS, MERS, and severe strains of influenza-like H1N1, COVID-19 induces intense inflammation in the lungs and a build-up of fluid, which is referred to clinically as edema.” Van Bokkelen, who holds a Ph.D. in genetics, says their treatment for patients with ARDS is encouraging.

Presently there are no FDA-approved therapies to treat ARDS. Critically ill COVID-19 patients with ARDS end up being put on a ventilator which pushes air through their lungs.

Scientists from the University of North Texas Health Science Center are also looking into the use of stem cells and are working with a team of international researchers to determine if stem cell therapy can be used for COVID-19 patients.

As the Lord Leads, Pray with Us…

  • For researchers in this country and elsewhere who are searching for therapeutic treatments for patients with the coronavirus.
  • For researchers and laboratories working on a possible vaccine against COVID-19.
  • For the FDA scientists as they look into the possibilities of approving stem cell therapies for COVID-19 patients.

Sources: Fox News, Life Science News


Back to top